AAAAAA

   
Results: 1-19 |
Results: 19
QUALITY-OF-LIFE DURING ACUTE AND INTERMITTENT TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE WITH OMEPRAZOLE COMPARED WITH RANITIDINE - RESULTS FROM A MULTICENTER CLINICAL-TRIAL
Authors: WIKLUND I BARDHAN K MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR D FULTON C GILLON K
Citation: I. Wiklund et al., QUALITY-OF-LIFE DURING ACUTE AND INTERMITTENT TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE WITH OMEPRAZOLE COMPARED WITH RANITIDINE - RESULTS FROM A MULTICENTER CLINICAL-TRIAL, The Italian Journal of Gastroenterology, 30(1), 1998, pp. 19-27
DO DISTINCTIVE FACES COME FROM OUTER-SPACE - AN INVESTIGATION OF THE STATUS OF A MULTIDIMENSIONAL FACE-SPACE
Authors: JOHNSTON RA MILNE AB WILLIAMS C HOSIE J
Citation: Ra. Johnston et al., DO DISTINCTIVE FACES COME FROM OUTER-SPACE - AN INVESTIGATION OF THE STATUS OF A MULTIDIMENSIONAL FACE-SPACE, Visual cognition, 4(1), 1997, pp. 59-67
EFFICACY AND TOLERABILITY OF MELOXICAM VERSUS PIROXICAM IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE - A 6-MONTH DOUBLE-BLIND-STUDY
Authors: HOSIE J DISTEL M BLUHMKI E
Citation: J. Hosie et al., EFFICACY AND TOLERABILITY OF MELOXICAM VERSUS PIROXICAM IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE - A 6-MONTH DOUBLE-BLIND-STUDY, Clinical drug investigation, 13(4), 1997, pp. 175-184
COST-EFFECTIVENESS (C-E) OF OMEPRAZOLE (OM) AND RANITIDINE (RAN) IN INTERMITTENT TREATMENT (IT) OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG FULTON C GILLON K PEACOCK R STALHAMMAR NO
Citation: Kd. Bardhan et al., COST-EFFECTIVENESS (C-E) OF OMEPRAZOLE (OM) AND RANITIDINE (RAN) IN INTERMITTENT TREATMENT (IT) OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gut, 41, 1997, pp. 203-203
SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) - INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS A STRATEGY FOR MANAGEMENT
Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG GILLON K PEACOCK R FULTON C
Citation: Kd. Bardhan et al., SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) - INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS A STRATEGY FOR MANAGEMENT, Gut, 41, 1997, pp. 203-203
THE IMPACT ON QUALITY-OF-LIFE IN INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS STRATEGIES FOR THE MANAGEMENT OF PATIENTS WITH SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG FULTON C GILLON K PEACOCK R WIKLUND I
Citation: Kd. Bardhan et al., THE IMPACT ON QUALITY-OF-LIFE IN INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS STRATEGIES FOR THE MANAGEMENT OF PATIENTS WITH SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gastroenterology, 112(4), 1997, pp. 65-65
COST-EFFECTIVENESS (C-E) OF OMEPRAZOLE (OM) AND RANITIDINE (RAN) IN INTERMITTENT TREATMENT (IT) OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG FULTON C GILLON K PEACOCK R STALHAMMAR NO
Citation: Kd. Bardhan et al., COST-EFFECTIVENESS (C-E) OF OMEPRAZOLE (OM) AND RANITIDINE (RAN) IN INTERMITTENT TREATMENT (IT) OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gastroenterology, 112(4), 1997, pp. 65-65
SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) - INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS A STRATEGY FOR MANAGEMENT
Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG GILLON K PEACOCK R FULTON C
Citation: Kd. Bardhan et al., SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) - INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS A STRATEGY FOR MANAGEMENT, Gastroenterology, 112(4), 1997, pp. 65-65
SPARFLOXACIN FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA - A POOLED DATA-ANALYSIS OF 2 STUDIES
Authors: AUBIER M LODE H GIALDRONIGRASSI G HUCHON G HOSIE J LEGAKIS N REGAMEY C SEGEV S VESTER R WIJNANDS WJ TOLSTUCHOW N
Citation: M. Aubier et al., SPARFLOXACIN FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA - A POOLED DATA-ANALYSIS OF 2 STUDIES, Journal of antimicrobial chemotherapy, 37, 1996, pp. 73-82
SAFETY AND EFFICACY OF SPARFLOXACIN IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A DOUBLE-BLIND, RANDOMIZED, PARALLEL, MULTICENTER STUDY
Authors: ALLEGRA L KONIETZKO N LEOPHONTE P HOSIE J PAUWELS R GUYEN JN PETITPRETZ P
Citation: L. Allegra et al., SAFETY AND EFFICACY OF SPARFLOXACIN IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A DOUBLE-BLIND, RANDOMIZED, PARALLEL, MULTICENTER STUDY, Journal of antimicrobial chemotherapy, 37, 1996, pp. 93-104
MELOXICAM IN OSTEOARTHRITIS - A 6-MONTH, DOUBLE-BLIND COMPARISON WITHDICLOFENAC SODIUM
Authors: HOSIE J DISTEL M BLUHMKI E
Citation: J. Hosie et al., MELOXICAM IN OSTEOARTHRITIS - A 6-MONTH, DOUBLE-BLIND COMPARISON WITHDICLOFENAC SODIUM, British journal of rheumatology, 35, 1996, pp. 39-43
MANAGING HYPERTENSION IN GENERAL-PRACTICE - CAN WE DO BETTER
Authors: HOSIE J WIKLUND I
Citation: J. Hosie et I. Wiklund, MANAGING HYPERTENSION IN GENERAL-PRACTICE - CAN WE DO BETTER, Journal of human hypertension, 9, 1995, pp. 15-18
TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA - A RANDOMIZED COMPARISON OF SPARFLOXACIN, AMOXICILLIN-CLAVULANIC ACID AND ERYTHROMYCIN
Authors: LODE H GARAU J GRASSI C HOSIE J HUCHON G LEGAKIS N SEGEV S WIJNANDS G
Citation: H. Lode et al., TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA - A RANDOMIZED COMPARISON OF SPARFLOXACIN, AMOXICILLIN-CLAVULANIC ACID AND ERYTHROMYCIN, The European respiratory journal, 8(12), 1995, pp. 1999-2007
THE EFFECT OF TENIDAP ON THE ANTIHYPERTENSIVE EFFICACY OF ACE-INHIBITORS IN PATIENTS TREATED FOR MILD-TO-MODERATE HYPERTENSION
Authors: RAPEPORT WG GRIMWOOD VC HOSIE J SLOAN PM KORLIPARA K SILVERT BD JAMES I MECHIE GL ANDERTON JL
Citation: Wg. Rapeport et al., THE EFFECT OF TENIDAP ON THE ANTIHYPERTENSIVE EFFICACY OF ACE-INHIBITORS IN PATIENTS TREATED FOR MILD-TO-MODERATE HYPERTENSION, British journal of clinical pharmacology, 39, 1995, pp. 57-61
A COMPARISON OF 5 DAYS OF DIRITHROMYCIN AND 7 DAYS OF CLARITHROMYCIN IN ACUTE BACTERIAL EXACERBATION OF CHRONIC-BRONCHITIS
Authors: HOSIE J QUINN P SMITS P SIDES G
Citation: J. Hosie et al., A COMPARISON OF 5 DAYS OF DIRITHROMYCIN AND 7 DAYS OF CLARITHROMYCIN IN ACUTE BACTERIAL EXACERBATION OF CHRONIC-BRONCHITIS, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 173-183
LONG-TERM TOLERABILITY OF A FIXED COMBINATION OF HYDROCHLOROTHIAZIDE (25 MG) AND LOW-DOSE LISINOPRIL (10 MG) ONCE-DAILY IN ESSENTIAL-HYPERTENSION
Authors: HOSIE J
Citation: J. Hosie, LONG-TERM TOLERABILITY OF A FIXED COMBINATION OF HYDROCHLOROTHIAZIDE (25 MG) AND LOW-DOSE LISINOPRIL (10 MG) ONCE-DAILY IN ESSENTIAL-HYPERTENSION, Drug development research, 1995, pp. 14-19
A COMPARATIVE-STUDY OF LONG-ACTING DILTIAZEM (TILDIEM LA) WITH SUSTAINED-RELEASE NIFEDIPINE (NIFEDIPINE SR) AND BENDROFLUAZIDE IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION
Authors: HOSIE J NASAR MA BELGRAVE GP WALTERS EG
Citation: J. Hosie et al., A COMPARATIVE-STUDY OF LONG-ACTING DILTIAZEM (TILDIEM LA) WITH SUSTAINED-RELEASE NIFEDIPINE (NIFEDIPINE SR) AND BENDROFLUAZIDE IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION, Acta cardiologica, 49(3), 1994, pp. 251-265
ANTITUSSIVE ACTIVITY AND TOLERABILITY OF MOGUISTEINE IN PATIENTS WITHACUTE COUGH - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: ADAMS R HOSIE J JAMES I KHONG T KOHN H SMITH I WADE A
Citation: R. Adams et al., ANTITUSSIVE ACTIVITY AND TOLERABILITY OF MOGUISTEINE IN PATIENTS WITHACUTE COUGH - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Advances in therapy, 10(6), 1993, pp. 263-271
FRAUD AND MALPRACTICE IN CLINICAL RESEARCH
Authors: HOSIE J
Citation: J. Hosie, FRAUD AND MALPRACTICE IN CLINICAL RESEARCH, Journal of the Royal College of Physicians of London, 27(2), 1993, pp. 198-198
Risultati: 1-19 |